Serotonin hypothesis of winter depression: Behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects

Psychiatry Research

Volumn 86, Issue 1, 1999, Pages 9-28

  Schwartz, Paul J ^a   Turner, Erick H ^b   Garcia Borreguero, Diego ^c   Sedway, Jan ^c   Vetticad, Rina G ^c   Wehr, Thomas A ^c   Murphy, Dennis L ^c   Rosenthal, Norman E ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

5 HT(1A) receptors; ACTH; Adrenocorticotropic hormone; Cortisol; Ipsapirone; Prolactin; Seasonal affective disorder

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CORTICOTROPIN; HYDROCORTISONE; IPSAPIRONE; PARTIAL AGONIST; PROLACTIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RATING SCALE; SEASONAL VARIATION; WINTER;

ADRENOCORTICOTROPIC HORMONE; ADULT; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, INTRAVENOUS; MALE; PIPERAZINES; PITUITARY-ADRENAL SYSTEM; PROLACTIN; PYRIMIDINES; RECEPTORS, SEROTONIN; RETROSPECTIVE STUDIES; SEASONAL AFFECTIVE DISORDER; SEROTONIN; SEROTONIN AGONISTS;

EID: 0033583452     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00017-7     Document Type: Article

References (109)

1. Anderson I.M., Cowen P.J. Effect of pindolol on endocrine and temperature response to buspirone in healthy volunteers. Psychopharmacology. 106:1992;428-432.
2. Anderson I.M., Cowen P.J., Grahame-Smith D.G. The effects of gepirone on neuroendocrine function and temperature in humans. Psychopharmacology. 100:1990;498-503.
3. Aulakh C.S., Hill J.L., Murphy D.L. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. Journal of Pharmacology and Experimental Therapeutics. 263:1992;588-595.
4. Avissar S., Schreiber G., Nechamkin Y., Neuhaus I., Lam G.K., Schwartz P.J., Turner E.H., Matthews J., Naim S., Rosenthal N.E. The effects of seasons and light therapy on G protein levels in mononuclear leukocytes of patients with seasonal affective disorder. Archives of General Psychiatry. 56:1999;178-183.
5. 1 agonists in rat. Neuroendocrinology. 50:1989;241-247.
6. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends in Pharmacological Science. 15:1994;220-226.
7. Brewerton T.D., Murphy D.L., Mueller E.A., Jimerson D.C. Induction of migraine-like headaches by the serotonin agonist m-CPP. Clinical Pharmacology and Therapeutics. 43:1988;605-609.
8. Broocks A., Briggs N.C., Pigott T.A., Hill J.L., Canter S.K., Tolliver T.J., Baldemore D., Murphy D.L. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment. Psychopharmacology. 130:1997;91-103.
9. Cagampang F.R.A., Inouye S.I.T. Diurnal and circadian changes of serotonin in the suprachiasmatic nuclei: regulation by light and an endogenous pacemaker. Brain Research. 639:1994;175-179.
10. Cagampang F.R.A., Yamazaki S., Otori Y., Inouye S.I.T. Serotonin in the raphe nuclei: regulation by light and an endogenous pacemaker. NeuroReport. 4:1993;49-52.
11. Calogero A.E., Bernardini R., Margioris A.N., Bagdy G., Gallucci W.T., Munson P.J., Tamarkin L., Tomai T.P., Brady L., Gold P.W., Chrousos G.P. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides. 10:1989;189-200.
12. Calogero A.E., Bagdy G., Szemeredi K., Tartaglia M.E., Gold P.W., Chrousos G.P. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 126:1990;1888-1894.
13. Calogero A.E., Bagdy G., Moncada M.L., D'Agata R. Effect of selective serotonin agonists on basal, corticotropin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. Journal of Endocrinology. 136:1993;381-387.
14. Carlsson P., Svennerholm L., Winblad B. Seasonal and circadian monoamine variations in human brains examined post-mortem. Acta Psychiatrica Scandinavica. 61(Suppl 280):1980;75-82.
15. Challet E., Scarbrough K., Penev P.D., Turek F.W. Roles of suprachiasmatic nuclei and intergeniculate leaflets in mediating the phase-shifting effects of a serotonergic agonist and their photic modulation during subjective day. Journal of Biological Rhythms. 13:1998;410-421.
16. Childs P.A., Rodin I., Martin N.J., Allen N.H.P., Plaskett L., Smythe P.J., Thompson C. Effect of fluoxetine on melatonin in patients with seasonal affective disorder and matched control subjects. British Journal of Psychiatry. 166:1995;196-198.
17. 1A receptor function in impulsive aggressive behavior in humans. Psychopharmacology Bulletin. 26:1990;393-405.
18. Coiro V., Volpi R., Marchesi C., De Ferri A., Davoli C., Caffarra P., Rossi G., Caffarri G., Davolio M., Chiodera P. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Psychoneuroendocrinology. 18:1993;551-556.
19. Cowen P.J., Anderson I.M., Grahame-Smith D.G. Neuroendocrine effects of azapirones. Journal of Clinical Psychopharmacology. 10:1990;21S-25S.
20. 1A receptor sensitivity in major depression: a neuroendocrine study with buspirone. British Journal of Psychiatry. 164:1994;372-379.
21. De Kloet E.R., Sybesma H., Reul J.H. Selective control by corticosterone of serotonin 1 receptor capacity in raphe-hippocampus system. Neuroendocrinology. 42:1986;513-521.
22. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-26.
23. Depue R.A., Arbisi P., Krauss S., Iacono W.G., Leon A., Muir R., Allen J. Seasonal independence of low prolactin concentration and high spontaneous eye blink rates in unipolar and bipolar II seasonal affective disorder. Archives of General Psychiatry. 47:1990;356-364.
24. Dilsaver S.C., Jaeckle R.S. Winter depression responds to an open trial of tranylcypromine. Journal of Clinical Psychiatry. 51:1990;326-329.
25. Fernstrom J.D., Wurtman R.J. Brain serotonin content: increase following ingestion of a carbohydrate diet. Science. 174:1971;1023-1025.
26. Ferraro J.S., Steger R.W. Diurnal variations in brain serotonin are driven by the photic cycle and are not circadian in nature. Brain Research. 512:1990;121-124.
27. Foote W.E., Taber-Pierce E., Edwards L. Evidence for a retinal projection to the midbrain raphe of the cat. Brain Research. 156:1978;135-140.
28. Fuller R.W. The involvement of serotonin in regulation of pituitary-adrenocortical function. Frontiers in Neuroendocrinology. 13:1992;250-270.
29. Garattini S., Caccia S., Mennini T., Mamamin R., Consolo S., Ladinsky H. Biochemical pharmacology of the anorectic drug fenfluramine: a review. Current Medical Research Opinion. 6(Suppl 6):1979;15-27.
30. Garcia-Borreguero D., Jacobsen F.M., Murphy D.L., Joseph-Vanderpool J.R., Chiara A., Rosenthal N.E. Hormonal responses to the administration of m-CPP in patients with seasonal affective disorder and control subjects. Biological Psychiatry. 37:1995;740-749.
31. Gelfin Y., Lerer B., Lesch K.P., Gorfine M., Allolio B. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects. Psychopharmacology. 120:1995;356-364.
32. 1A receptor subtype increases rat plasma ACTH secretion. European Journal of Pharmacology. 147:1988;431-439.
33. 1A receptor-dependent responses more in females. European Journal of Pharmacology. 164:1989;435-443.
34. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 12:1960;56-62.
35. 1 recognition sites. Journal of Receptor Research. 8:1988;59-81.
36. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.E., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews. 46:1994;157-203.
37. Jacobs B.L. Serotonin and behavior: emphasis on motor control. Journal of Clinical Psychiatry. 52:1991;17-23.
38. Jacobsen F.M., Sack D.A., Wehr T.A., Rogers S., Rosenthal N.E. Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. Archives of General Psychiatry. 44:1987;1086-1091.
39. Jacobsen F.M., Mueller E.A., Rosenthal N.E., Rogers S., Hill J.L., Murphy D.L. Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Research. 52:1994;181-197.
40. Joseph-Vanderpool J.R., Rosenthal N.E., Chrousos G.P., Wehr T.A., Skwerer R., Kasper S., Gold P.W. Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. Journal of Clinical Endocrinology and Metabolism. 72:1991;1382-1387.
41. Joseph-Vanderpool J.R., Jacobsen F.M., Murphy D.L., Hill J.L., Rosenthal N.E. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and control subjects. Biological Psychiatry. 33:1993;496-504.
42. Jouvet M. Biogenic amines and the states of sleep. Science. 163:1969;32-41.
43. Kahn R.S., Wetzler S. m-Chlorphenylpiperazine as a probe of serotonin function. Biological Psychiatry. 30:1991;1139-1166.
44. Kahn R.S., Trestman R., Lawlor B.A., Gabriel S., Davidson M., Siever L. Effects of ipsapirone in healthy subjects: a dose-response study. Psychopharmacology. 114:1994;155-160.
45. Kasper, S., Neumeister, A., Rieder, N., Heßelmann, B., Ruhrmann, S., 1996. Serotonergic mechanisms in the pathophysiology and treatment of seasonal affective disorder. In: Holick, M.F., Jung, E.G. (Eds.), Biologic Effects of Light 1995. Walter de Gruyter and Company, pp. 325-331.
46. 1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. Brain Research. 782:1998;1-10.
47. 1A receptor-mediated effects of buspirone, gepirone, and ipsapirone. Pharmacology, Biochemistry and Behavior. 29:1988;711-715.
48. Krauchi K., Wirz-Justice A., Graw P. The relationship of affective state to dietary preference: winter depression and light therapy as a model. Journal of Affective Disorders. 20:1990;43-53.
49. Lam R.W., Gorman C.P., Michalon M., Steiner M., Levitt A.J., Corral M.R., Watson G.D., Morehouse R.L., Tam W., Joffe R.T. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry. 152:1995;1765-1770.
50. Lam R.W., Zis A.P., Grewal A.K., Delgado P.G., Charney D.S., Krystal J.H. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Archives of General Psychiatry. 53(1):1996;41-44.
51. Lam R.W., Levitan R.D., Tam E.M., Yatham L.N., Lamoureux S., Zis A.P. L-Tryptophan augmentation of light therapy in patients with seasonal affective disorder. Canadian Journal of Psychiatry. 42:1997;303-306.
52. 1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in the rat. Journal of Pharmacology and Experimental Therapeutics. 280:1997;1241-1249.
53. Lesch K.P., Lerer B. The 5-HT receptor-G-protein-effector complex in depression. I. Effect of glucocorticoids. Journal of Neural Transmission [Gen Sect]. 84:1991;3-18.
54. Lesch K.P., Rupprecht R., Poten B., Müller U., Söhnle K., Fritze J., Schulte H.M. Endocrine response to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biological Psychiatry. 26:1989;203-205.
55. 1A receptor responsivity in unipolar depression: evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and control subjects. Biological Psychiatry. 28:1990;620-628.
56. 1A) receptor activation: effects of 5-HT receptor and β-adrenoreceptor antagonists. Journal of Clinical Endocrinology and Metabolism. 70:1990;670-674.
57. 1A receptor responsivity in obsessive- compulsive disorder: comparison of patients and control subjects. Archives of General Psychiatry. 48:1991;540-547.
58. Levitan R.D., Kaplan A.S., Brown G.M., Vaccarino F.J., Kennedy S.H., Levitt A., Joffe R.T. Hormonal and subjective responses to intravenous m-chlorophenylpiperzine in women with seasonal affective disorder. Archives of General Psychiatry. 55:1998;244-249.
59. 7) implicated in the regulation of mammalian circadian rhythms. Neuron. 11:1993;449-458.
60. Maj J., Chojnacka-Wojcik E., Tatarczynska E., Klodzinska A. Central action of ipsapirone, a new anxiolytic drug on serotonergic, noradrenergic and dopaminergic functions. Journal of Neural Transmission. 70:1987;1-17.
61. Maskall D.D., Zis A.P., Lam R.W., Clark C.M., Kuan A.J. Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biological Psychiatry. 38:1995;235-239.
62. McGrath R.E., Buckwald B., Resnick E.V. The effect of L-tryptophan on seasonal affective disorder. Journal of Clinical Psychiatry. 51:1990;162-163.
63. Meltzer H.Y., Maes M. Effects of buspirone on plasma prolactin and cortisol levels in major depression and normal subjects. Biological Psychiatry. 35:1994;316-323.
64. Meltzer H.Y., Maes M. Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biological Psychiatry. 38:1995;450-457.
65. Meltzer H.Y., Flemming T., Robertson A. The effect of buspirone on prolactin and growth hormone secretion in man. Archives of General Psychiatry. 40:1983;1099-1102.
66. 1A receptor stimulation. Archives of General Psychiatry. 49:1992;163-164.
67. Miguez J.M., Aldegunde M. Changes in the hypothalamic serotonergic function may mediate the endocrine effects of melatonin. Journal of Physiology and Biochemistry. 52:1996;239-246.
68. Miguez J.M., Martin F.J., Aldegunde M. Melatonin effects on serotonin synthesis and metabolism in the striatum, nucleus accumbens, and dorsal and median raphe nuclei of rats. Neurochemical Research. 22:1997;87-92.
69. 1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Journal of Pharmacology and Experimental Therapeutics. 264:1993;1364-1376.
70. 2A-adrenergic receptors in relation to modulation of cortical monoamine release and potential antidepressant properties. Journal of Pharmacology and Experimental Therapeutics. 282:1997;132-147.
71. Moja E.A., Cipolla P., Castoda D., Tofanetti O. Dose-responsive decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sciences. 44:1989;971-976.
72. Monsma F.J., Shen Y., Wark R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Molecular Pharmacology. 43:1993;320-327.
73. Murphy D.L., Mueller E.A., Hill J.L., Tolliver T.J., Jacobsen F.M. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology. 98:1989;275-282.
74. Murphy D.L., Lesch K.P., Aulakh C.S., Pigott T.A. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacological Reviews. 43:1991;527-552.
75. 1A receptor control on pineal melatonin concentrations in the rat. European Neuropsychopharmacology. 8:1998;183-186.
76. 3H-ICS 205-930. Naunyn Schmiedebergs Archives of Pharmacology. 337:1988;493-499.
77. Neumeister A., Praschak-Rieder N., Heßelmann B., Rao M.-L., Glück J., Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Archives of General Psychiatry. 54:1997;133-138.
78. Neumeister A., Praschak-Rieder N., Heßelmann B., Vitouch D., Rauh M., Barocka A., Kasper S. Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer. Psychological Medicine. 28:1998;257-264.
79. Neumeister A., Turner E.H., Matthews J.R., Postolache T.T., Barnett R.L., Rauh M., Vetticad R.G., Kasper S., Rosenthal N.E. Effects of tryptophan depletion vs. catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Archives of General Psychiatry. 55:1998;524-530.
80. O'Rourke D., Wurtman J.J., Wurtman R.J., Chebli R., Gleason R. Treatment of seasonal depression with d-fenfluramine. Journal of Clinical Psychiatry. 50(9):1989;343-347.
81. Oren D.A., Levendosky A.A., Kasper S., Duncan C.C., Rosenthal N.E. Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biological Psychiatry. 39:1996;157-170.
82. Partonen T., Lönnqvist J. Moclobemide and fluoxetine in treatment of seasonal affective disorder. Journal of Affective Disorders. 41:1996;93-99.
83. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the humans brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience. 21:1987;97-122.
84. Pigott T.A., Zohar J., Hill J.L., Bernstein S.E., Grover G.N., Zohar-Kadouch R.C., Murphy D.L. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biological Psychiatry. 29:1991;418-426.
85. Pigott T.A., Hill J.L., Grady T.A., L'Heureux F., Bernstein S., Rubenstein C.S., Murphy D.L. A comparison of the behavioral effects of oral vs. intravenous m-CPP administration in OCD patients and the effects of metergoline prior to IV m-CPP. Biological Psychiatry. 33:1993;3-14.
86. Rosenthal, N.E., Blehar, M.C., 1989. Seasonal Affective Disorders and Phototherapy. Guilford Publications, New York.
87. Rosenthal N.E., Sack D.A., Gillin J.C., Lewy A.J., Goodwin F.K., Davenport Y., Mueller P.S., Newsome D.A., Wehr T.A. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry. 41:1984;72-80.
88. Rosenthal N.E., Genhart M.J., Caballero B., Jacobsen F.M., Skwerer R.G., Coursey R.D., Rogers S., Spring B.J. Psychobiological effects of carbohydrate- and protein-rich meals in patients with seasonal affective disorder and normal control subjects. Biological Psychiatry. 25:1989;1029-1040.
89. Rosenthal, N.E., Schwartz, P.J., Leibenluft, E., Peeke, P., Turner, E.H., Oren, D.A., Gold, P.W., Wehr, T.A., 1995. Evidence for hypothalamic disturbance in seasonal affective disorder. Proceedings of the Society for Light Treatment and Biological Rhythms, vol. 7, Frankfurt, Germany.
90. Ruhrman S., Kasper S., Hawellek B., Martinez B., Höfilch G., Nickelsen T., Möller H.J. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD). Pharmacopsychiatry. 26:1993;193.
91. 3 antagonists. Psychoneuroendocrinology. 20:1994;239-257.
92. Schwartz P.J., Wehr T.A., Rosenthal N.E., Bartko J.J., Oren D.A., Luetke C., Murphy D.L. Serotonin and thermoregulation: physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology. 13:1995;105-115.
93. Schwartz P.J., Murphy D.L., Wehr T.A., Garcia-Borreguero D., Oren D.A., Moul D.E., Ozaki N., Snelbaker A.J., Rosenthal N.E. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects: diurnal responses and nocturnal regulatory mechanisms. Archives of General Psychiatry. 54:1997;375-385.
94. Schwartz P.J., Rosenthal N.E., Turner E.H., Drake C.L., Wehr T.A. Seasonal variation in core temperature regulation during sleep in patients with winter-seasonal affective disorder. Biological Psychiatry. 42:1997;122-131.
95. Schwartz P.J., Rosenthal N.E., Wehr T.A. Serotonin 1A receptors, melatonin, and the proportional control thermostat in patients with winter depression. Archives of General Psychiatry. 55:1998;897-903.
96. Seibyl J.P., Krystal J.H., Price L.H., Woods S.W., D'Amico C., Heninger G.R., Charney D.S. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Research. 38:1991;227-236.
97. 1A receptor activation by flesinoxan in humans; body temperature and neuroendocrine responses. Neuropsychopharmacology. 13:1995;93-104.
98. Shen H., Semba K. A direct retinal projection to the dorsal raphe nucleus in the rat. Brain Research. 635:1994;159-168.
99. 7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Molecular Pharmacology. 47:1995;99-103.
100. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1989. Structured Clinical Interview for DSM-III-R Patient Edition (SCID-P, 9/1/89 version), Biometrics Research Department, New York State Psychiatric Institute, New York.
101. Swade C., Coppen A. Seasonal variation in biochemical factors related to depressive illness. Journal of Affective Disorders. 2:1980;249-255.
102. van Kammen D.P., Murphy D.L. Attenuation of the euphoriant and activation effects of D- and L-amphetamine by lithium carbonate treatment. Psychopharmacologia. 44:1975;215-244.
103. Van Wijngaarden I.V., Tulp M.T., Soudijn W. The concept of selectivity in 5-HT receptor research. European Journal of Pharmacology. 129:1990;123-130.
104. Wehr T.A. The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). Journal of Clinical Endocrinology and Metabolism. 73:1991;1276-1280.
105. Williams, J.B.W., Link, M.J., Rosenthal, N.E., Terman, M., 1988. Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorders Version (SIGH-SAD), New York State Psychiatric Institute.
106. Wirz-Justice A., Richter R. Seasonality in biochemical determinations: a source of variance and a clue to the temporal incidence of affective illness. Psychiatry Research. 1:1979;53-60.
107. Yatham L.N., Michalon M. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder. Psychoneuroendocrinology. 20:1995;433-438.
108. 1D agonist) challenge in seasonal affective disorder: effects of light therapy. Biological Psychiatry. 42:1997;24-29.
109. 1A receptor function in rodents. Neuropharmacology. 31:1992;433-438.